Logo image of GAN

GAN LTD (GAN) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:GAN - BMG3728V1090 - Common Stock

1.97 USD
+0.01 (+0.51%)
Last: 5/23/2025, 8:18:27 PM
1.9601 USD
-0.01 (-0.5%)
After Hours: 5/23/2025, 8:18:27 PM
Fundamental Rating

2

GAN gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 132 industry peers in the Hotels, Restaurants & Leisure industry. GAN may be in some trouble as it scores bad on both profitability and health. GAN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year GAN has reported negative net income.
In the past year GAN had a positive cash flow from operations.
GAN had negative earnings in each of the past 5 years.
GAN had negative operating cash flow in 4 of the past 5 years.
GAN Yearly Net Income VS EBIT VS OCF VS FCFGAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

1.2 Ratios

With a Return On Assets value of -14.14%, GAN is not doing good in the industry: 87.31% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -14.14%
ROE N/A
ROIC N/A
ROA(3y)-80.41%
ROA(5y)-52.93%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GAN Yearly ROA, ROE, ROICGAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500

1.3 Margins

GAN has a Gross Margin of 68.73%. This is amongst the best in the industry. GAN outperforms 82.09% of its industry peers.
In the last couple of years the Gross Margin of GAN has declined.
The Profit Margin and Operating Margin are not available for GAN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 68.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.66%
GM growth 5Y-1.7%
GAN Yearly Profit, Operating, Gross MarginsGAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

2

2. Health

2.1 Basic Checks

GAN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GAN has been increased compared to 1 year ago.
Compared to 5 years ago, GAN has more shares outstanding
Compared to 1 year ago, GAN has a worse debt to assets ratio.
GAN Yearly Shares OutstandingGAN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
GAN Yearly Total Debt VS Total AssetsGAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

GAN has an Altman-Z score of -3.56. This is a bad value and indicates that GAN is not financially healthy and even has some risk of bankruptcy.
GAN's Altman-Z score of -3.56 is on the low side compared to the rest of the industry. GAN is outperformed by 94.03% of its industry peers.
The Debt to FCF ratio of GAN is 11.79, which is on the high side as it means it would take GAN, 11.79 years of fcf income to pay off all of its debts.
GAN has a Debt to FCF ratio (11.79) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 11.79
Altman-Z -3.56
ROIC/WACCN/A
WACC7.12%
GAN Yearly LT Debt VS Equity VS FCFGAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

GAN has a Current Ratio of 1.57. This is a normal value and indicates that GAN is financially healthy and should not expect problems in meeting its short term obligations.
GAN has a Current ratio of 1.57. This is in the better half of the industry: GAN outperforms 75.37% of its industry peers.
GAN has a Quick Ratio of 1.57. This is a normal value and indicates that GAN is financially healthy and should not expect problems in meeting its short term obligations.
GAN has a Quick ratio of 1.57. This is in the better half of the industry: GAN outperforms 76.87% of its industry peers.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 1.57
GAN Yearly Current Assets VS Current LiabilitesGAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

4

3. Growth

3.1 Past

GAN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 71.43%, which is quite impressive.
GAN shows a small growth in Revenue. In the last year, the Revenue has grown by 7.02%.
Measured over the past years, GAN shows a very strong growth in Revenue. The Revenue has been growing by 35.10% on average per year.
EPS 1Y (TTM)71.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-44.44%
Revenue 1Y (TTM)7.02%
Revenue growth 3Y2.82%
Revenue growth 5Y35.1%
Sales Q2Q%-4.19%

3.2 Future

GAN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.04% yearly.
The Revenue is expected to grow by 3.90% on average over the next years.
EPS Next Y47.61%
EPS Next 2Y6.55%
EPS Next 3Y13.04%
EPS Next 5YN/A
Revenue Next Year-4.82%
Revenue Next 2Y2.15%
Revenue Next 3Y3.9%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
GAN Yearly Revenue VS EstimatesGAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
GAN Yearly EPS VS EstimatesGAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 -1 -2 -3 -4

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GAN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GAN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GAN Price Earnings VS Forward Price EarningsGAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, GAN is valued a bit more expensive than the industry average as 74.63% of the companies are valued more cheaply.
Based on the Price/Free Cash Flow ratio, GAN is valued a bit cheaper than the industry average as 69.40% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 22.44
EV/EBITDA 31.02
GAN Per share dataGAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

A more expensive valuation may be justified as GAN's earnings are expected to grow with 13.04% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.55%
EPS Next 3Y13.04%

0

5. Dividend

5.1 Amount

No dividends for GAN!.
Industry RankSector Rank
Dividend Yield N/A

GAN LTD

NASDAQ:GAN (5/23/2025, 8:18:27 PM)

After market: 1.9601 -0.01 (-0.5%)

1.97

+0.01 (+0.51%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)05-09 2025-05-09/amc
Earnings (Next)08-07 2025-08-07/amc
Inst Owners31.54%
Inst Owner Change-12.87%
Ins Owners7.71%
Ins Owner Change0%
Market Cap91.53M
Revenue(TTM)133.71M
Net Income(TTM)-10.63M
Analysts46.67
Price Target2.01 (2.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1219.36%
Min EPS beat(2)-2327.72%
Max EPS beat(2)-111%
EPS beat(4)2
Avg EPS beat(4)-556.24%
Min EPS beat(4)-2327.72%
Max EPS beat(4)177.66%
EPS beat(8)3
Avg EPS beat(8)-288.04%
EPS beat(12)5
Avg EPS beat(12)-466.6%
EPS beat(16)6
Avg EPS beat(16)-402.26%
Revenue beat(2)0
Avg Revenue beat(2)-21.32%
Min Revenue beat(2)-23.68%
Max Revenue beat(2)-18.97%
Revenue beat(4)2
Avg Revenue beat(4)-8.85%
Min Revenue beat(4)-23.68%
Max Revenue beat(4)5.93%
Revenue beat(8)3
Avg Revenue beat(8)-9.89%
Revenue beat(12)3
Avg Revenue beat(12)-8.37%
Revenue beat(16)5
Avg Revenue beat(16)-6.79%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)54%
EPS NY rev (1m)0%
EPS NY rev (3m)-112.82%
Revenue NQ rev (1m)-6.59%
Revenue NQ rev (3m)-7.27%
Revenue NY rev (1m)-8.67%
Revenue NY rev (3m)-13.99%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.68
P/FCF 22.44
P/OCF 12.53
P/B N/A
P/tB N/A
EV/EBITDA 31.02
EPS(TTM)-0.2
EYN/A
EPS(NY)-0.14
Fwd EYN/A
FCF(TTM)0.09
FCFY4.46%
OCF(TTM)0.16
OCFY7.98%
SpS2.88
BVpS-0.35
TBVpS-0.7
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -14.14%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 68.73%
FCFM 3.05%
ROA(3y)-80.41%
ROA(5y)-52.93%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.66%
GM growth 5Y-1.7%
F-Score4
Asset Turnover1.78
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 11.79
Debt/EBITDA 14.97
Cap/Depr 41.36%
Cap/Sales 2.41%
Interest Coverage N/A
Cash Conversion 227.42%
Profit Quality N/A
Current Ratio 1.57
Quick Ratio 1.57
Altman-Z -3.56
F-Score4
WACC7.12%
ROIC/WACCN/A
Cap/Depr(3y)45.66%
Cap/Depr(5y)80.76%
Cap/Sales(3y)5.61%
Cap/Sales(5y)8.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)71.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-44.44%
EPS Next Y47.61%
EPS Next 2Y6.55%
EPS Next 3Y13.04%
EPS Next 5YN/A
Revenue 1Y (TTM)7.02%
Revenue growth 3Y2.82%
Revenue growth 5Y35.1%
Sales Q2Q%-4.19%
Revenue Next Year-4.82%
Revenue Next 2Y2.15%
Revenue Next 3Y3.9%
Revenue Next 5YN/A
EBIT growth 1Y83.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1701.45%
EBIT Next 3Y226.63%
EBIT Next 5YN/A
FCF growth 1Y128.56%
FCF growth 3YN/A
FCF growth 5Y0.48%
OCF growth 1Y314.28%
OCF growth 3YN/A
OCF growth 5Y0.79%

GAN LTD / GAN FAQ

What is the fundamental rating for GAN stock?

ChartMill assigns a fundamental rating of 2 / 10 to GAN.


Can you provide the valuation status for GAN LTD?

ChartMill assigns a valuation rating of 1 / 10 to GAN LTD (GAN). This can be considered as Overvalued.


How profitable is GAN LTD (GAN) stock?

GAN LTD (GAN) has a profitability rating of 1 / 10.


What is the expected EPS growth for GAN LTD (GAN) stock?

The Earnings per Share (EPS) of GAN LTD (GAN) is expected to grow by 47.61% in the next year.